Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.82M
-
Shares change
-
+230K
-
Total reported value, excl. options
-
$4.44M
-
Value change
-
+$533K
-
Number of buys
-
9
-
Number of sells
-
-9
-
Price
-
$2.43
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q3 2020
22 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q3 2020.
Anixa Biosciences Inc - Common Stock (ANIX) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.82M shares
of 37.9M outstanding shares and own 4.82% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (657K shares), UBS Group AG (528K shares), Qube Research & Technologies Ltd (137K shares), GEODE CAPITAL MANAGEMENT, LLC (102K shares), BlackRock Inc. (87K shares), AVANTAX ADVISORY SERVICES, INC. (53.2K shares), NORTHERN TRUST CORP (52K shares), TWO SIGMA INVESTMENTS, LP (39.5K shares), Bank of New York Mellon Corp (39.4K shares), and TWO SIGMA ADVISERS, LP (36.3K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.